SUNLENCY Trademark

Trademark Overview


On Thursday, March 5, 2020, a trademark application was filed for SUNLENCY with the United States Patent and Trademark Office. The USPTO has given the SUNLENCY trademark a serial number of 88823359. The federal status of this trademark filing is REGISTERED as of Tuesday, May 23, 2023. This trademark is owned by Gilead Sciences Ireland UC. The SUNLENCY trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
sunlency

General Information


Serial Number88823359
Word MarkSUNLENCY
Filing DateThursday, March 5, 2020
Status700 - REGISTERED
Status DateTuesday, May 23, 2023
Registration Number7058021
Registration DateTuesday, May 23, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
Translation of Words in MarkThe wording "SUNLENCY" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE

Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE

Trademark Events


Event DateEvent Description
Tuesday, May 23, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 23, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, April 20, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, March 9, 2023NOTICE OF ALLOWANCE CANCELLED
Thursday, April 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 9, 2023TEAS DELETE 1(B) BASIS RECEIVED
Friday, August 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 24, 2022SOU EXTENSION 3 GRANTED
Wednesday, August 24, 2022SOU EXTENSION 3 FILED
Wednesday, August 24, 2022TEAS EXTENSION RECEIVED
Friday, March 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2022SOU EXTENSION 2 GRANTED
Wednesday, March 16, 2022SOU EXTENSION 2 FILED
Wednesday, March 16, 2022TEAS EXTENSION RECEIVED
Wednesday, November 10, 2021ASSIGNED TO EXAMINER
Saturday, August 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 19, 2021SOU EXTENSION 1 GRANTED
Thursday, August 19, 2021SOU EXTENSION 1 FILED
Thursday, August 19, 2021TEAS EXTENSION RECEIVED
Tuesday, April 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 8, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, September 20, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, September 20, 2020LETTER OF SUSPENSION E-MAILED
Sunday, September 20, 2020SUSPENSION LETTER WRITTEN
Wednesday, September 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 26, 2020ASSIGNED TO LIE
Thursday, August 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 28, 2020NON-FINAL ACTION E-MAILED
Thursday, May 28, 2020NON-FINAL ACTION WRITTEN
Sunday, May 24, 2020ASSIGNED TO EXAMINER
Wednesday, March 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 9, 2020NEW APPLICATION ENTERED